1. A Randomized Controlled Trial to Compare Once- versus Twice-Daily Filgrastim for Mobilization of Peripheral Blood Stem Cells from Healthy Donors 
Yukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, Kinuko Mitani, Kimiko Iijima, Jun-ichi Ueyama, Satoshi Yoshihara, Koichiro Yuji, Sung-won Kim, Toshihiko Ando, Masahiro Kami, Emi Yamamoto, Kiyoshi Hiruma, Shin-ichiro Mori, Hisamaru Hirai, Hisashi Sakamaki 
Biology of Blood and Marrow Transplantation 
Volume 12, Issue 4, Pages (April 2006)
DOI: /j.bbmt
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Number of CD34+ cells per donor body weight (kg) collected on day 4 of G-CSF administration before (A) and after (B) logarithmic transformation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Peripheral blood WBC count before mobilization grouped according to outcome of mobilization. Poor mobilizers were defined as those with collection of less than 2.0 × 106 CD34+ cells per donor body weight (kg) on day 4 of filgrastim administration.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Correlation between age and number of CD34+ cells per donor body weight (kg) collected on day 4 of G-CSF administration.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions